<DOC>
	<DOC>NCT02209714</DOC>
	<brief_summary>The objective of the study is to obtain information about the safety and tolerability of BIIF 1149 BS45 (single dose: 40, 65, 100 mg), to determine the pharmacologically active dose (range) by performing a citric acid challenge test and to obtain preliminary pharmacokinetic data.</brief_summary>
	<brief_title>Safety, Tolerability and Pharmacodynamics After Oral Administration of BIIF 1149 BS in Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy males, based on a complete medical examination Age range from 21 to 50 years +/ 20 % of their normal weight (BrocaIndex) Written informed consent Volunteers will be excluded from the study if the results of the medical examination or laboratory tests are judged by the clinical investigator to differ significantly from normal clinical values Volunteers with known gastrointestinal, hepatic, renal, respiratory, cardiovascular, metabolic, immunological or hormonal disorders Volunteers with diseases of the central nervous system (such as epilepsy) or with psychiatric disorders Volunteers with known history of orthostatic hypotension, fainting spells or blackouts Volunteers with chronic or relevant acute infections (especially respiratory infections, cough) Volunteers with history of allergy/hypersensitivity (including drug allergy) which is deemed relevant to the trial as judged by the investigator Volunteers who have taken a drug with a long halflife (≥ 24 hours) within ten halflives of the respective drug before enrolment in the study Volunteers who received any other drugs which might influence the results of the study during the week prior to the start of the study Volunteers who have participated in another study with an investigational drug within the last 2 months preceding this study Volunteers who smoke more than 10 cigarettes (or equivalent) per day Volunteers who are not able to refrain from smoking on study days Volunteers who drink more than 40 g of alcohol per day Volunteers who are dependent on drugs Volunteers who are participated in excessive physical activities (e.g. competitive sports) during the last week before the study Volunteers who have donated blood (≥ 100 ml) within the last four weeks</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>